Sharon Cantor

8PUBLICATIONS
10CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsProteomics and intermolecular interactions (excl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 08, 2026
Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response.

|Jan 21, 2025
Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability.

Jenna M Whalen, Jillian Earley, Christi Silva

|Mar 24, 2024
FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells.

Ke Cong, Nathan MacGilvary, Silviana Lee

|Jan 08, 2021
Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability.

Sumeet Nayak, Jennifer A Calvo, Sharon B Cantor

|Jun 25, 2020
Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.

Sumeet Nayak, Jennifer A Calvo, Ke Cong

|Jan 13, 2019
TPX2 joins 53BP1 to maintain DNA repair and fork stability.

Sharon Cantor

Pageof 2

Frequent Collaborators

2 joint publications

Sumeet Nayak

2 joint publications

Nathan MacGilvary

2 joint publications

Christi Wisniewski

1 joint publications

Jennifer A Calvo